Though there’s still snow on the ground across much of the country, baseball fans celebrated the start of Spring Training this week, signaling that warm weather is just around the corner. If you’re looking to get “ahead in the count” of your professional development, take a crack at this week’s Research Ethics Roundup.
Ethics of 2 U.S.-funded cancer studies in India questioned: Two separate U.S.-funded studies of cervical cancer in India are the subject of growing controversy. Researchers conducting the study neglected to screen members of the control group for cervical cancer and failed to obtain adequate informed consent from all those enrolled in the trial. According to this article, at least 79 of the women from the control arms of these studies have died from complications relating to cervical cancer.
Redefine misconduct as distorted reporting: This article from Nature posits that the research community should redefine misconduct as “any omission or misrepresentation of the information necessary and sufficient to evaluate the validity and significance of research, at the level appropriate to the context in which the research is communicated.” Requiring researchers to be more transparent about their techniques and findings may provide a fairer method of curbing the unsettling proliferation of misconduct within the field.
Unethical stem cells?: According to a review of human embryonic stem cell (hESC) lines approved by the National Institutes of Health, 49 stem cell lines currently in use may have been “derived from sperm or egg donors who did not give proper consent for the use of their biological material in research.”
Looking for more news? PRIM&R members can visit our Knowledge Center to find more recent scholarly journal and popular media articles pertaining to research ethics. Not yet a member? Learn more about becoming a member by visiting our website.